Decreased trabecular bone biomechanical competence, apparent density, IGF-II and IGFBP-5 content in acromegaly

European Journal of Clinical Investigation

Volumn 32, Issue 2, 2002, Pages 122-128

  Ueland, Thor ^a   Ebbesen, E N ^b   Thomsen, J S ^c,d   Mosekilde, L ^c,d   Brixen, K ^c   Flyvbjerg, A ^c   Bollerslev, J ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

^c AARHUS UNIVERSITY HOSPITAL   (Denmark)

^d AARHUS UNIVERSITY   (Denmark)

Author keywords

Acromegaly; Biomechanical competence; Growth hormone; Insulin like growth factors; pQCT; Trabecular bone

Indexed keywords

CALCIUM; CHLORIDE; GUANIDINE; OSTEOCALCIN; SOMATOMEDIN; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN BINDING PROTEIN 5; SOMATOMEDIN C;

ACROMEGALY; ADULT; BIOMECHANICS; BONE BIOPSY; BONE DENSITY; BONE LEVEL; BONE MATRIX; CALCIUM BONE LEVEL; CLINICAL ARTICLE; COMPRESSION; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; HORMONE DETERMINATION; HUMAN; HUMAN TISSUE; HYDROLYSIS; ILIAC CREST; MALE; PRIORITY JOURNAL; TRABECULAR BONE;

ACROMEGALY; ADULT; BIOMECHANICS; BONE DENSITY; CASE-CONTROL STUDIES; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 5; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; MALE; MIDDLE AGED; OSTEOCALCIN;

EID: 0037003047     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.2002.00944.x     Document Type: Conference Paper

References (34)

1. Albright F, Reifenstein EC. The Parathyroid Glands and Metabolic Bone Disease. Selected Studies. Baltimore: Williams and Wilkins;1948:pp.188-96.
2. Avioli LV, Raisz LG. Bone metabolism and disease. In: Bondy P, Rosenberg L, editors. Metabolic Control and Disease. Philadelphia; W.B. Saunders;1980:pp.1709-814.
3. Diamond T, Nery L, Posen S. Spinal and peripheral bone mineral densities in acromegaly: the effects of excess growth hormone and hypogonadism. Ann Intern Med 1989;111:567-73.
4. Ezzat S, Melmed S, Endres D, Eyre DR, Singer FR. Biochemical assessment of bone formation and resorption in acromegaly. J Clin Endocrinol Metab 1993;76:1452-7.
5. Longobardi S, Di Somma C, Di Rella F, Angelillo N, Ferone D, Colao A et al. Bone mineral density and circulating cytokines in patients with acromegaly. J Endocrinol Invest 1998;21:688-93.
6. Kayath MJ, Vieira JG. Osteopenia occurs in a minority of patients with acromegaly and is predominant in the spine. Osteoporos Int 1997;7:226-30.
7. Jockenhovel F, Rohrbach S, Deggerich S, Reinwein D, Reiners C. Differential presentation of cortical and trabecular peripheral bone mineral density in acromegaly. Eur J Med Res 1996;1:377-82.
8. Kotzmann H, Bernecker P, Hubsch P, Pietschmann P, Woloszczuk W, Svoboda T et al. Bone mineral density and parameters of bone metabolism in patients with acromegaly. J Bone Miner Res 1993;8:459-65.
9. Lesse GP, Fraser WD, Farquharson R, Hipkin L, Vora JP. Gonadal status is an important determinant of bone density in acromegaly. Clin Endocrinol 1998;48:59-65.
10. Scillitani A, Chiodini I, Carnevale V, Giannatempo GM, Frusciante V, Villella M et al. Skeletal involvement in female acromegalic subjects: the effects of growth hormone excess in amenorrheal and menstruating patients. J Bone Miner Res 1997;12:1729-36.
11. Mbuyi-Muamba JM, Dequeker J. Biochemical anatomy of human bone: comparative study of compact and spongy bone in femur, rib and iliac crest. Acta Anat 1987;128:184-7.
12. Ninomiya JT, Tracy RP, Calore JD, Gendreau MA, Kelm RJ, Mann KG. Heterogeneity of human bone. J Bone Miner Res 1990;5:933-8.
13. de la Piedra C, Larranaga J, Castro N, Horcajada C, Rapado A, Herrera Pombo JL et al. Correlation among plasma osteocalcin, growth hormone, and somatomedin C in acromegaly. Calcif Tissue Int 1988;43:44-5.
14. Halse J, Melsen F, Mosekilde Le. Iliac crest bone mass and remodelling in acromegaly. Acta Endocrinol 1981;97:18-22.
15. Hayden JM, Mohan S, Baylink DJ. The insulin-like growth factor system and the coupling of formation to resorption. Bone 1995;17:93S-8S.
16. Nicolas V, Mohan S, Honda Y, Prewett A, Finkelman RD, Baylink DJ et al. An age-related decrease in the concentration of insulin-like growth factor binding protein-5 in human cortical bone. Calcif Tissue Int 1995;57:206-12.
17. Ueland T, Bollerslev J, Hansen TB, Ebbesen EN, Mosekilde L, Brixen K et al. Increased cortical bone content of insulin-like growth factors in acromegalic patients. J Clin Endocrinol Metab 1999;84:123-7.
18. Mosekilde Li Viidik A, Mosekilde Le. Correlation between the compressive strength of iliac and vertebral trabecular bone in normal individuals. Bone 1985;6:291-85.
19. Ebbesen EN, Thomsen JS, Mosekilde Le. Nondestructive determination of iliac crest cancellous bone strength by pQCT. Bone 1997;21:535-40.
20. Mosekilde L, Danielsen CC. Biomechanical competence of vertebral trabecular bone in relation to ash density and age in normal individuals. Bone 1987;8:79-85.
21. Aerssens J, Boonen S, Joly J, Dequeker J. Variations in trabecular bone composition with anatomical site and age: potential implications for bone quality assessment. J Endocrinol 1997;155:411-21.
22. Seck T, Scheppach B, Scharla S, Diel I, Blum WF, Bismar H et al. Concentration of insulin-like growth factor (IGF)-I and -II in iliac crest bone matrix from pre- and postmenopausal women: relationship to age, menopause, bone turnover, bone volume, and circulating IGFs. J Clin Endocrinol Metab 1998;83:2331-7.
23. Mohan S, Baylink DJ. Development of a simple valid method for the complete removal of insulin-like growth factor (IGF)-binding proteins from IGFs in human serum and journal biological fluids: comparison with acid- ethanol treatment and C18 Sep-Pak separation. J Clin Endocrinol Metab 1995;80:637-47.
24. Ulrich MM, Perizonius WR, Spoor CF, Sandberg P, Vermeer C. Extraction of osteocalcin from fossil bones and teeth. Biochem Biophys Res Commun 1987;149:712-19.
25. Flyvbjerg A, Kessler U, Dorka B, Funk B, Orskov H, Kiess W. Transient increase in renal insulin-like growth factor binding proteins during initial kidney hypertrophy in experimental diabetes in rats. Diabetologia 1992;35:589-93.
26. Riggs BL, Randall RV, Wahner HW, Jowsey J, Kelly PJ, Singh M. The nature of the metabolic bone disorder in acromegaly. J Clin Endocrinol Metab 1972;34:911-18.
27. Lindsay R. Estrogen/progestogen therapy: prevention and treatment of postmenopausal osteoporosis. Proc Soc Exp Biol Med 1989;191:275-7.
28. Rosen HN, Chen V, Cittadini A, Greenspan SL, Douglas PS, Moses AC et al. Treatment with growth hormone and IGF-I in growing rats increases bone mineral content but not bone mineral density. J Bone Miner Res 1995;10:1352-8.
29. Tobias JH, Chow JW, Chambers TJ. Opposite effects of insulin-like growth factor-I on the formation of trabecular and cortical bone in adult female rats. Endocrinology 1992;131:2387-92.
30. Grynpas MD, Holmyard D. Changes in quality of bone mineral on aging and in disease. Scanning Microsc 1988;2:1045-54.
31. Bailey AJ, Sims TJ, Ebbesen EN, Mansell JP, Thomsen JS, Mosekilde L. Age-related changes in the biochemical properties of human cancellous bone collagen: relationship to bone strength. Calcif Tissue Int 1999;65:203-10.
32. Malpe R, Baylink DJ, Linkhart TA, Wergedal JE, Mohan S. Insulin-like growth factor (IGF)-I-II, IGF binding proteins (IGFBP)-3, -4, and -5 levels in the conditioned media of normal human bone cells are skeletal site-dependent. J Bone Miner Res 1997;12:423-30.
33. Martin JL, Willetts KE, Baxter RC. Purification and properties of a novel insulin-like growth factor-II binding protein from transformed human fibroblasts. J Biol Chem 1990;265:4124-30.
34. Boonen S, Mohan S, Dequeker J, Aerssens J, Vanderschueren D, Verbeke G et al. Down-regulation of the serum stimulatory components of the insulin-like growth factor (IGF) system (IGF-I, IGF-II, IGF binding protein [BP]-3, and IGFBP-5) in age-related (type II) femoral neck osteoporosis. J Bone Miner Res 1999;14:2150-8.